Fortis Healthcare Limited (FORTIS) — Financial Results Announcement
Fortis Healthcare Limited reported audited consolidated net profit of **₹106,419 lakhs** for FY2025-26, up from ₹136,585 lakhs in the prior year, reflecting a **69.9% YoY increase** in profitability. The company recommended a final dividend of **₹1 per share** (10% of ₹10 face value), subject to shareholder approval at the upcoming AGM. Revenue stood at **₹912,784 lakhs**, with total expenses at **₹780,676 lakhs**, resulting in a net profit margin of **12.10%**. The audit report issued by BSR & Co. LLP confirmed an unmodified opinion and no material uncertainty regarding going concern. Segment-wise, Healthcare contributed ₹777,269 lakhs in revenue and ₹139,370 lakhs in profit, while Diagnostics generated ₹152,656 lakhs in revenue and ₹24,185 lakhs in profit. The company also disclosed ongoing regulatory scrutiny, including investigations by EOW, SEBI, and ED into past related-party transactions and fund diversions, though it assessed the financial impact as low and non-material. Additionally, Fortis Healthcare approved a scheme of amalgamation and demerger, implemented employee stock option schemes, and recorded provisions for contingencies related to legal matters.
📄 View Original Announcement (PDF)
About Fortis Healthcare Limited (FORTIS)
Healthcare · Healthcare Services · Listed on NSE
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.